EFSCE
FPRX

Enterprise Financial Services Corp (EFSC)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-29
Closed -$1K – 1070
2016
Q1 		$1K Buy
+29
New +$997 ﹤0.01% 1016

Other funds holding FPRX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s FPRX Position: Q2 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2016, closing a stake of 29 shares — an estimated $1K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in FPRX in Q1 2016 and held it in 1 quarter. The position peaked at $1K in Q1 2016. 170 funds tracked by Wall St. Rank hold FPRX as of Q2 2016.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 29 Five Prime Therapeutics, Inc. shares in Q2 2016, an estimated $1K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Five Prime Therapeutics, Inc. in Q1 2016 and held it in 1 quarter.
  • Enterprise Financial Services Corp (EFSC)'s Five Prime Therapeutics, Inc. position peaked at $1K in Q1 2016.
  • 170 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q2 2016, filed 29 Jul 2016.